NEO-MEDROL ACNE LOTION 100 MG
ALUMINUM CHLOROHYDRATE : 100 MG SULFUR : 50 MG METHYLPREDNISOLONE ACETATE : 2.5 MG NEOMYCIN SULFATE : 2.5 MG · DIN 00195057 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is NEO-MEDROL ACNE LOTION?
NEO-MEDROL ACNE LOTION 100 MG contains ALUMINUM CHLOROHYDRATE : 100 MG SULFUR : 50 MG METHYLPREDNISOLONE ACETATE : 2.5 MG NEOMYCIN SULFATE : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 00195057, held by PFIZER CANADA ULC, supplied as LOTION for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Feb-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NEO-MEDROL ACNE LOTION used for?
Control of acne vulgaris in adolescents and young adults. Also used in some cases of acne rosacea and seborrheic dermatitis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00195057 |
|---|---|
| Brand name | NEO-MEDROL ACNE LOTION |
| Generic / active ingredient | ALUMINUM CHLOROHYDRATE : 100 MG SULFUR : 50 MG METHYLPREDNISOLONE ACETATE : 2.5 MG NEOMYCIN SULFATE : 2.5 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 100 MG |
| Dosage form | LOTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D10AA02 METHYLPREDNISOLONE |
| AHFS class | 84:06.00 ; 84:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Feb-2022 |
| Original market date | 1965-12-31 00:00:00 |
How is it administered?
Apply sparingly to affected areas once or twice a day after cleansing. Frequency may be reduced to every other day depending on skin sensitivity to the drying effect. Avoid eye contact.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
null
How is it supplied?
Plastic squeeze bottles of 25 mL and 75 mL.
Contraindications
Tuberculosis of the skin, herpes simplex, vaccinia, varicella, other cutaneous infections not responding to neomycin, and known hypersensitivity to any components.
Warnings and precautions
Avoid eye contact. Discontinue if irritation develops. Risk of overgrowth by resistant organisms. Potential for systemic corticosteroid absorption if used on extensive areas or with occlusion.
What can be used instead?
Other Canadian products sharing ATC code D10AA02 METHYLPREDNISOLONE. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MEDROL ACNE LOTION | 50 MG | LOTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00252395 |
Who else supplies METHYLPREDNISOLONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METHYLPREDNISOLONE appears in 18 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.